EARLY INITIATION OF HIGH-DOSE SIMVASTATIN DURING ST-ELEVATION MYOCARDIAL INFARCTION DECREASES THE INCIDENCE OF CARDIOVASCULAR EVENTS, EVEN IN PATIENTS WITH LOW ADMISSION LDL CHOLESTEROL LEVELS

Abstract

Early initiation of statin therapy during acute phase of ST-elevation myocardial infarction (STEMI) has been considered controversial particularly in patients with low plasma levels of low-density lipoprotein cholesterol (LDL-C). In this context we aimed to evaluate the impact of early use of statin